Cargando…
Anti-CD19 CAR-T as a feasible and safe treatment against central nervous system leukemia after intrathecal chemotherapy in adults with relapsed or refractory B-ALL
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756216/ https://www.ncbi.nlm.nih.gov/pubmed/30846865 http://dx.doi.org/10.1038/s41375-019-0437-5 |
| _version_ | 1783453362978553856 |
|---|---|
| author | He, Xiaoyuan Xiao, Xia Li, Qing Jiang, Yanyu Cao, Yaqing Sun, Rui Jin, Xin Yuan, Ting Meng, Juanxia Ma, Li Lu, Wenyi Lyu, Cuicui Liu, Kaiqi Zhao, Mingfeng |
| author_facet | He, Xiaoyuan Xiao, Xia Li, Qing Jiang, Yanyu Cao, Yaqing Sun, Rui Jin, Xin Yuan, Ting Meng, Juanxia Ma, Li Lu, Wenyi Lyu, Cuicui Liu, Kaiqi Zhao, Mingfeng |
| author_sort | He, Xiaoyuan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6756216 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67562162019-09-26 Anti-CD19 CAR-T as a feasible and safe treatment against central nervous system leukemia after intrathecal chemotherapy in adults with relapsed or refractory B-ALL He, Xiaoyuan Xiao, Xia Li, Qing Jiang, Yanyu Cao, Yaqing Sun, Rui Jin, Xin Yuan, Ting Meng, Juanxia Ma, Li Lu, Wenyi Lyu, Cuicui Liu, Kaiqi Zhao, Mingfeng Leukemia Letter Nature Publishing Group UK 2019-03-07 2019 /pmc/articles/PMC6756216/ /pubmed/30846865 http://dx.doi.org/10.1038/s41375-019-0437-5 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter He, Xiaoyuan Xiao, Xia Li, Qing Jiang, Yanyu Cao, Yaqing Sun, Rui Jin, Xin Yuan, Ting Meng, Juanxia Ma, Li Lu, Wenyi Lyu, Cuicui Liu, Kaiqi Zhao, Mingfeng Anti-CD19 CAR-T as a feasible and safe treatment against central nervous system leukemia after intrathecal chemotherapy in adults with relapsed or refractory B-ALL |
| title | Anti-CD19 CAR-T as a feasible and safe treatment against central nervous system leukemia after intrathecal chemotherapy in adults with relapsed or refractory B-ALL |
| title_full | Anti-CD19 CAR-T as a feasible and safe treatment against central nervous system leukemia after intrathecal chemotherapy in adults with relapsed or refractory B-ALL |
| title_fullStr | Anti-CD19 CAR-T as a feasible and safe treatment against central nervous system leukemia after intrathecal chemotherapy in adults with relapsed or refractory B-ALL |
| title_full_unstemmed | Anti-CD19 CAR-T as a feasible and safe treatment against central nervous system leukemia after intrathecal chemotherapy in adults with relapsed or refractory B-ALL |
| title_short | Anti-CD19 CAR-T as a feasible and safe treatment against central nervous system leukemia after intrathecal chemotherapy in adults with relapsed or refractory B-ALL |
| title_sort | anti-cd19 car-t as a feasible and safe treatment against central nervous system leukemia after intrathecal chemotherapy in adults with relapsed or refractory b-all |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756216/ https://www.ncbi.nlm.nih.gov/pubmed/30846865 http://dx.doi.org/10.1038/s41375-019-0437-5 |
| work_keys_str_mv | AT hexiaoyuan anticd19cartasafeasibleandsafetreatmentagainstcentralnervoussystemleukemiaafterintrathecalchemotherapyinadultswithrelapsedorrefractoryball AT xiaoxia anticd19cartasafeasibleandsafetreatmentagainstcentralnervoussystemleukemiaafterintrathecalchemotherapyinadultswithrelapsedorrefractoryball AT liqing anticd19cartasafeasibleandsafetreatmentagainstcentralnervoussystemleukemiaafterintrathecalchemotherapyinadultswithrelapsedorrefractoryball AT jiangyanyu anticd19cartasafeasibleandsafetreatmentagainstcentralnervoussystemleukemiaafterintrathecalchemotherapyinadultswithrelapsedorrefractoryball AT caoyaqing anticd19cartasafeasibleandsafetreatmentagainstcentralnervoussystemleukemiaafterintrathecalchemotherapyinadultswithrelapsedorrefractoryball AT sunrui anticd19cartasafeasibleandsafetreatmentagainstcentralnervoussystemleukemiaafterintrathecalchemotherapyinadultswithrelapsedorrefractoryball AT jinxin anticd19cartasafeasibleandsafetreatmentagainstcentralnervoussystemleukemiaafterintrathecalchemotherapyinadultswithrelapsedorrefractoryball AT yuanting anticd19cartasafeasibleandsafetreatmentagainstcentralnervoussystemleukemiaafterintrathecalchemotherapyinadultswithrelapsedorrefractoryball AT mengjuanxia anticd19cartasafeasibleandsafetreatmentagainstcentralnervoussystemleukemiaafterintrathecalchemotherapyinadultswithrelapsedorrefractoryball AT mali anticd19cartasafeasibleandsafetreatmentagainstcentralnervoussystemleukemiaafterintrathecalchemotherapyinadultswithrelapsedorrefractoryball AT luwenyi anticd19cartasafeasibleandsafetreatmentagainstcentralnervoussystemleukemiaafterintrathecalchemotherapyinadultswithrelapsedorrefractoryball AT lyucuicui anticd19cartasafeasibleandsafetreatmentagainstcentralnervoussystemleukemiaafterintrathecalchemotherapyinadultswithrelapsedorrefractoryball AT liukaiqi anticd19cartasafeasibleandsafetreatmentagainstcentralnervoussystemleukemiaafterintrathecalchemotherapyinadultswithrelapsedorrefractoryball AT zhaomingfeng anticd19cartasafeasibleandsafetreatmentagainstcentralnervoussystemleukemiaafterintrathecalchemotherapyinadultswithrelapsedorrefractoryball |